Legislation (Treatment-Related Instruments) Sunset-altering Declaration 2024
1Legislation (Treatment-Related Instruments) Sunset-altering Declaration 2024
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in Legislation (Treatment-Related Instruments) Sunset-altering Declaration 2024.
meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8
?xml version="1.0" encoding="utf-8" standalone="no"?>
Commonwealth Coat of Arms of Australia
Legislation (Treatment‑related Instruments) Sunset‑altering Declaration 2024
I, Mark Dreyfus KC, Attorney‑General, make the following declaration.
Dated 15 February 2024
Mark Dreyfus KC
Attorney‑General
Contents
1 Name
2 Commencement
3 Authority
4 Aligning of sunsetting
5 Repeal of this instrument
1 Name
This instrument is the Legislation (Treatment-related Instruments) Sunset-altering Declaration 2024.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
- Commencement information
- Column 1 Column 2 Column 3
- Provisions Commencement Date/Details
-
- The whole of this instrument The day after this instrument is registered. 21 February 2024
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsection 51A(1) of the Legislation Act 2003.
4 Aligning of sunsetting
The instruments mentioned in the following table are repealed by section 51A of the Legislation Act 2003 on 1 October 2026.
- Repeals of instruments
- Item Instrument name FRL identifier
- 1 MRCA Pharmaceutical Benefits Scheme F2021C00166
- 2 MRCA Private Patient Principles 2004 F2015L01339
- 3 MRCA Treatment Principles F2022C01001
- 4 Repatriation Pharmaceutical Benefits Scheme F2021C00172